Image 1
Cabergoline Tablet
Product Images NDC 0093-5420
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 0093-5420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a medication label for Cabergoline tablets USP 0.5mg. Each tablet contains cabergoline, USP 05mg. It should be dispensed in the original container. The label also includes a product code (NDC 0093-5420-88) and a phone number (98-0245-6600).*
Image 3
This is a description of a medication called Cabergoline, which comes in the form of tablets with a strength of 0.5mg. The tablets are required to be dispensed in their original container and stored at a controlled temperature of 20° to 25°C. The medication should not be lacquered or tampered with in any way. Usual dosage instructions are found in the package insert. The medication is manufactured in the Czech Republic by TEVA Czech Industries s.r.0. on behalf of TEVA PHARMACEUTICALS USA, INC. It is essential to keep all medications out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
